Physician profile
Per Sommer
NPI 1396075297
$27,454.11
in general payments reported to CMS, 2019-2025
18 companies · $9,201 in 2025
The $9,201 reported for 2025 was more than what 88% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $978 · 2020: $566 · 2021: $1,511 · 2022: $838 · 2023: $6,620 · 2024: $7,740 · 2025: $9,201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Consulting Fee: $8,480 · Travel and Lodging: $4,247 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,815.05 |
| Consulting Fee | $8,480.00 |
| Travel and Lodging | $4,247.38 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $21,387.32 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Abbott Laboratories | $2,955.62 | 2020-2025 | Cardiomems, Gallant, Aveir |
| Abiomed | $591.84 | 2023-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $520.15 | 2023-2025 | Lifevest |
| Siemens Medical Solutions USA, INC. | $500.00 | 2021 | |
| Medtronic, INC. | $483.73 | 2023 | Corevalve Evolut R |
| Boston Scientific Corporation | $463.96 | 2019-2025 | General - Therapies, Farapulse, Rotapro |
| Teleflex LLC | $227.31 | 2024 | Manta |
| Atricure, INC. | $64.38 | 2023-2024 | |
| Kestra Medical Technology Services, INC. | $49.24 | 2024-2025 | Assure Wcd |
| Novartis Pharmaceuticals Corporation | $40.93 | 2024-2025 | |
| Amgen INC. | $29.02 | 2023 | Repatha |
| Cvrx, INC. | $28.66 | 2024 | Barostim Neo System |
| Cardiva Medical, INC. | $25.99 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Janssen Pharmaceuticals, INC | $24.92 | 2024 | Xarelto |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $21.90 | 2025 | Angio-Seal |
| Getinge USA Sales, LLC | $20.29 | 2023 | Cardiosave Hybrid, Type B Plug |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.85 | 2025 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Per Sommer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.